Parallel Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Parallel Advisors's HALO Position: Q1 2026 in Review
Parallel Advisors increased its Halozyme (HALO) stake by 7.8% in Q1 2026, buying an estimated $10.4K and bringing the position to 2,028 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.
Parallel Advisors first reported a position in HALO in Q2 2019 and has held it in 28 quarters since. The position peaked at $138K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Parallel Advisors held 2,028 shares of Halozyme worth $131K as of Q1 2026.
- Parallel Advisors bought 147 Halozyme shares in Q1 2026, an estimated $10.4K.
- Halozyme made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1428 holding.
- Parallel Advisors first reported a position in Halozyme in Q2 2019 and has held it in 28 quarters since.
- Parallel Advisors's Halozyme position peaked at $138K in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.